Published in
Royal Society of Chemistry, MedChemComm, 11(6), p. 1930-1941
DOI: 10.1039/c5md00274e
Links
Tools
Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease
Journal article published in 2015 by
Gary Tin 
,
Tarek Mohamed,
Nyasha Gondora,
Michael A. Beazely,
Praveen P. N. Rao
,
Tarek Mohamed,
Nyasha Gondora,
Michael A. Beazely,
Praveen P. N. Rao
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A group of tricyclic phenothiazines (6a, 6b and 7a–l) and phenoselenazines (12a, 12b and 13a–l) was designed, synthesized and evaluated as multi-targeting ligands aimed at the cholinergic, amyloid and oxidative stress pathways of Alzheimer's disease.